{"id":"https://openalex.org/W1968014398","doi":"https://doi.org/10.4088/jcp.v59n0508","title":"A Double-Blind, Placebo-Controlled Trial of Nefazodone in the Treatment of Patients Hospitalized for Major Depression","display_name":"A Double-Blind, Placebo-Controlled Trial of Nefazodone in the Treatment of Patients Hospitalized for Major Depression","publication_year":1998,"publication_date":"1998-05-15","ids":{"openalex":"https://openalex.org/W1968014398","doi":"https://doi.org/10.4088/jcp.v59n0508","mag":"1968014398","pmid":"https://pubmed.ncbi.nlm.nih.gov/9632036"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v59n0508","doi":"https://doi.org/10.4088/jcp.v59n0508","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v59n0508","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112066093","display_name":"John P. Feighner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Feighner","raw_affiliation_strings":["Feighner Research Institute, San Diego, Calif 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Feighner Research Institute, San Diego, Calif 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071455209","display_name":"Steven D. Targum","orcid":"https://orcid.org/0000-0003-1054-5197","observed_orcids":["https://orcid.org/0000-0003-1054-5197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven D. Targum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108386214","display_name":"Mary Ellen Bennett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Ellen Bennett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114077379","display_name":"Douglas L. Roberts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas L. Roberts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043476032","display_name":"Terry T. Kensler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terry T. Kensler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M. Frances D'Amico","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Frances D'Amico","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054062566","display_name":"Sterling A. Hardy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sterling A. Hardy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6903,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.84291773,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"59","issue":"5","first_page":"246","last_page":"253"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nefazodone","display_name":"nefazodone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9879999756813049},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.6169999837875366},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.9020000100135803},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.5339999794960022},{"id":"https://openalex.org/keywords/dysthymia","display_name":"dysthymia","score":0.8379999995231628},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6700000166893005},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6729999780654907},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7409999966621399},{"id":"https://openalex.org/keywords/hamilton-depression-rating-scale","display_name":"Hamilton Depression Rating Scale","score":0.7049999833106995},{"id":"https://openalex.org/keywords/montgomery-asberg-depression-rating-scale","display_name":"Montgomery-Asberg Depression Rating Scale","score":0.9110000133514404},{"id":"https://openalex.org/keywords/sleep-disturbance","display_name":"sleep disorders","score":0.5040000081062317},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.4650000035762787},{"id":"https://openalex.org/keywords/anergia","display_name":"anergia","score":0.4359999895095825},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2779419675","wikidata":"https://www.wikidata.org/wiki/Q416632","display_name":"Nefazodone","level":5,"score":0.9928260445594788},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8569389581680298},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5737296938896179},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.551727294921875},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5130959749221802},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48233291506767273},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4531944990158081},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.44415128231048584},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.44257768988609314},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.44095727801322937},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33749473094940186},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.3280482888221741},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.2748086452484131},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.2719486355781555},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.12839409708976746},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.08881396055221558},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017668","descriptor_name":"Age of Onset","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v59n0508","doi":"https://doi.org/10.4088/jcp.v59n0508","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v59n0508","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:9632036","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9632036","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2415051875","https://openalex.org/W2391684833","https://openalex.org/W2091962952","https://openalex.org/W72266852","https://openalex.org/W2440671558","https://openalex.org/W2348562048","https://openalex.org/W2396282970","https://openalex.org/W2348737506","https://openalex.org/W2410330785","https://openalex.org/W2010745218"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1],"are":[2],"few":[3],"published":[4],"placebo-controlled":[5],"clinical":[6,344],"trials":[7],"demonstrating":[8],"the":[9,12,25,33,93,107,110,115,118,126,129,188,209,214,261,264,274,283,292,331,353,372],"efficacy":[10,26],"of":[11,27,35,52,92,109,117,128,190,203,263,276,285,294,322,333,346,356,363],"newer":[13],"antidepressants":[14],"in":[15,32,48,85,161,201,208,231,250,309,330,339],"markedly":[16],"or":[17,153,157,184],"severely":[18],"depressed":[19],"hospitalized":[20,37,55],"patients.":[21],"This":[22],"study":[23,65,119],"demonstrates":[24],"nefazodone":[28,121,173,204,268,347],"compared":[29,47,103],"with":[30,104,172,229,245,247,303,365],"placebo":[31,44,105,329,369],"treatment":[34,45,83,112,191,196,311,332,357],"patients":[36,54,76,134,138,170,177,295,317,340],"for":[38,56,79,98],"major":[39,59,234,337],"depression.":[40],"METHOD:":[41],"Nefazodone":[42,82,287,325],"and":[43,75,218,222,259,279,291],"were":[46,77,205],"a":[49,86,155,180],"6-week":[50],"trial":[51],"120":[53],"DSM-III-R":[57],"diagnosed":[58],"depression":[60,235,338],"(without":[61],"psychosis)":[62],"at":[63,187,273,282],"2":[64,258,278],"centers.":[66],"Efficacy":[67],"was":[68,270,288,301,326,348],"evaluated":[69],"using":[70],"standard":[71],"psychiatric":[72],"rating":[73],"scales,":[74],"monitored":[78],"safety.":[80],"RESULTS:":[81],"resulted":[84],"significant":[87,238,248,305,366],"reduction":[88,160],"(p":[89,150,165,192,198,240],"<":[90,183,199,241],".01)":[91,200],"17-item":[94],"Hamilton":[95],"Rating":[96,212],"Scale":[97],"Depression":[99,211],"(HAM-D-17)":[100],"total":[101],"score":[102,149,182],"from":[106,368],"end":[108,116,127,189,262,275,284],"first":[111,354],"week":[113,257,277,355],"through":[114,260],"(-12.2":[120],"vs.":[122],"-7.7":[123],"placebo).":[124],"At":[125],"trial,":[130],"significantly":[131],"more":[132,169],"nefazodone-treated":[133,314],"(50%)":[135],"than":[136,175,315],"placebo-treated":[137,176,316],"(29%)":[139],"had":[140,179],"responded,":[141],"as":[142,254,256,350,352,358],"indicated":[143],"by":[144,154,360],"their":[145,162],"Clinical":[146],"Global":[147],"Impressions-Improvement":[148],"=":[151,158,166,185,193],".021)":[152],">":[156],"50%":[159],"HAM-D-17":[163,181],"scores":[164],".017).":[167],"Significantly":[168],"treated":[171,244],"(36%)":[174],"(14%)":[178],"10":[186],".004).":[194],"Significant":[195],"differences":[197,249,367],"favor":[202],"also":[206,236],"seen":[207,253],"Montgomery-Asberg":[210],"Scale;":[213],"HAM-D":[215,223],"retardation,":[216],"anxiety,":[217],"sleep":[219],"disturbance":[220],"factors;":[221],"item":[224],"1":[225],"(depressed":[226],"mood).":[227],"Patients":[228],"dysthymia":[230],"addition":[232],"to":[233,298,320,328,335],"showed":[237],"improvement":[239],".05)":[242],"when":[243],"nefazodone,":[246],"response":[251],"rates":[252],"early":[255,351],"trial.":[265,373],"The":[266,343],"mean":[267],"dose":[269],"491":[271],"mg/day":[272,281],"503":[280],"treatment.":[286],"well":[289],"tolerated,":[290],"number":[293],"discontinuing":[296],"owing":[297,319],"adverse":[299],"events":[300],"small,":[302],"no":[304],"safety":[306],"issues":[307],"noted":[308],"either":[310],"group.":[312],"Fewer":[313],"discontinued":[318],"lack":[321],"efficacy.":[323],"CONCLUSION:":[324],"superior":[327],"marked":[334],"severe":[336],"requiring":[341],"hospitalization.":[342],"benefit":[345],"evident":[349],"judged":[359],"several":[361],"measures":[362],"efficacy,":[364],"sustained":[370],"throughout":[371]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}